POU5F1 enhances the invasiveness of cancer stem-like cells in lung adenocarcinoma by upregulation of MMP-2 expression

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Xin, Yan Hong ^a   Bian, Bai Shi Jiao ^a,d   Yang, Xiao Jun ^a   Cui, Wei ^a   Cui, Hong Juan ^c   Cui, You Hong ^a   Zhang, Xia ^a   Xu, Chuan ^a,b   Bian, Xiu Wu ^a  

^a SOUTHWEST HOSPITAL   (China)

^b General Hospital of PLA Chengdu Military Area Command   (China)

^c SOUTHWEST UNIVERSITY   (China)

^d CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MICE; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PROGNOSIS;

EID: 84893521019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083373     Document Type: Article

References (33)

1. Sutherland KD, Berns A (2010) Cell of origin of lung cancer. Mol Oncol 4: 397-403.
2. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, et al. (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514. (Pubitemid 351267301)
3. Sullivan JP, Minna JD (2010) Tumor oncogenotypes and lung cancer stem cell identity. Cell Stem Cell 7: 2-4.
4. Levina V, Marrangoni A, Wang T, Parikh S, Su Y, et al. (2010) Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. Cancer Res 70: 338-346.
5. Rivera C, Rivera S, Loriot Y, Vozenin MC, Deutsch E (2011) Lung cancer stem cell: new insights on experimental models and preclinical data. J Oncol 2011: 549181.
6. Duan JJ, Qiu W, Xu SL, Wang B, Ye XZ, et al. (2013) Strategies for Isolating and Enriching Cancer Stem Cells: Well Begun Is Half Done. Stem Cells and Development 22: 2221-2239.
7. Xu C, Xie D, Yu SC, Yang XJ, He LR, et al. (2013) beta-Catenin/POU5F1/ SOX2 Transcription Factor Complex Mediates IGF-I Receptor Signaling and Predicts Poor Prognosis in Lung Adenocarcinoma. Cancer Res 73: 3181-3189.
8. Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, et al. (2008) Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 3: e2637.
9. Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, et al. (2010) Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 70: 10433-10444.
10. Jung M, Peterson H, Chavez L, Kahlem P, Lehrach H, et al. (2010) A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells. PLoS One 5: e10709.
11. Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL, et al. (2008) Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 68: 6281-6291.
12. Kobayashi K, Takahashi H, Inoue A, Harada H, Toshimori S, et al. (2012) Oct-3/4 promotes migration and invasion of glioblastoma cells. J Cell Biochem 113: 508-517.
13. Bruna A, Darken RS, Rojo F, Ocana A, Penuelas S, et al. (2007) High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11: 147-160. (Pubitemid 46209848)
14. Wang J, Pursell NW, Samson ME, Atoyan R, Ma AW, et al. (2013) Potential Advantages of CUDC-101, a Multi-Targeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion. Mol Cancer Ther 12: 925-936.
15. Yu SC, Xiao HL, Jiang XF, Wang QL, Li Y, et al. (2012) Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin. Stem Cells 30: 108-120.
16. Badiga AV, Chetty C, Kesanakurti D, Are D, Gujrati M, et al. (2011) MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS One 6: e20614.
17. Wang CK, Cao JG, Peng B, Gu YX, Zheng GP, et al. (2010) Inhibition of growth and motility of human A549 lung carcinoma cells by a recombined vascular basement membrane derived peptide. Cancer Lett 292: 261-268.
18. Kim Y, Jeoung D (2009) The cancer/testis antigen CAGE induces MMP-2 through the activation of NF-kappaB and AP-1. BMB Rep 42: 758-763.
19. Sobin LH WC, editors (2002) TNM classification of malignant tumors, 6th edition. New York: John Wiley & Sons.
20. He LR, Zhao HY, Li BK, Zhang LJ, Liu MZ, et al. (2010) Overexpression of AIB1 negatively affects survival of surgically resected non-small-cell lung cancer patients. Ann Oncol 21: 1675-1681.
21. Marsden CG, Wright MJ, Pochampally R, Rowan BG (2009) Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action. Methods Mol Biol 590: 363-375.
22. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, et al. (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450: 1235-1239.
23. Sueblinvong V, Weiss DJ (2010) Stem cells and cell therapy approaches in lung biology and diseases. Transl Res 156: 188-205.
24. Xu X, Dong Z, Li Y, Yang Y, Yuan Z, et al. (2013) The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation. Int J Biochem Cell Biol 45: 536-545.
25. Babaie Y, Herwig R, Greber B, Brink TC, Wruck W, et al. (2007) Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells 25: 500-510. (Pubitemid 46232806)
26. Bjorklund M, Koivunen E (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755: 37-69. (Pubitemid 40720240)
27. Littlepage LE, Sternlicht MD, Rougier N, Phillips J, Gallo E, et al. (2010) Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res 70: 2224-2234.
28. Wu KC, Yang ST, Hsia TC, Yang JS, Chiou SM, et al. (2012) Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. Anticancer Res 32: 4833-4842.
29. Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, et al. (2012) Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGFbeta1 signaling pathway. J Immunol 189: 444-453.
30. Chien MH, Lin CW, Cheng CW, Wen YC, Yang SF (2013) Matrix metalloproteinase-2 as a target for head and neck cancer therapy. Expert Opin Ther Targets 17: 203-216.
31. Shi M, Yu B, Gao H, Mu J, Ji C (2013) Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis. Mol Biol Rep 40: 617-623.
32. Zhang X, Han B, Huang J, Zheng B, Geng Q, et al. (2010) Prognostic significance of OCT4 expression in adenocarcinoma of the lung. Jpn J Clin Oncol 40: 961-966.
33. Qian Q, Wang Q, Zhan P, Peng L, Wei SZ, et al. (2010) The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis. Cancer Invest 28: 661-669.